Harmony Biosciences HRMY
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$6.08M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 38.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 7.10% to 11.44% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Allspring Global Investments, LLC | Mutual Fund | 2026/Q3 | +951,273 | 1.9% |
| Emerald Advisers, LLC | Mutual Fund | 2026/Q3 | +578,630 | 1.0% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +573,906 | 5.3% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +393,166 | 0.7% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +271,274 | 3.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +259,923 | 12.5% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +256,387 | 4.5% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +202,200 | 2.4% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q3 | +199,521 | 0.4% |
| Handelsbanken Asset Management | Mutual Fund | 2026/Q3 | +180,626 | 0.4% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +171,370 | 1.1% |
| Penn Capital Management Company, LLC | Mutual Fund | 2026/Q3 | +149,366 | 0.3% |
| LSV Asset Management | Mutual Fund | 2026/Q3 | +143,780 | 3.8% |
| Valor Management LLC | VC/PE Fund | 2026/Q3 | +700,883 | 1.4% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +434,333 | 4.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 17 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Intent to Sell (Form 144) | -35,852 | $42.74 | – |
| 17 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Derivative Exercise and Sale | -38,452 | $43.05 | 13,115 |
| 16 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Intent to Sell (Form 144) | -800 | $42.21 | – |
| 15 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Intent to Sell (Form 144) | -1,800 | $42.17 | – |
| 7 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Derivative Exercise and Sale | -22,954 | $43.10 | 13,115 |
| 7 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Automatic Disposition | -11,000 | $42.79 | 13,115 |
| 3 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Intent to Sell (Form 144) | -5,500 | $41.86 | – |
| 6 Aug 2026 | Valor Management LLC | Intent to Sell (Form 144) | -700,883 | $37.90 | – | |
| 15 Jul 2026 | Stephen Mollichella | Senior VP, Controller & Interim Principal Financial Officer | Initial Statement of Beneficial | +0 | – | 48,472 |
| 1 Jul 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -25,000 | $36.96 | – |
| 29 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -50,000 | $36.08 | – |
| 25 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -45,594 | $35.24 | – |
| 23 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -4,406 | $35.02 | – |
| 8 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -27,960 | $33.74 | – |
| 4 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -2,101 | $33.08 | – |
| 3 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -7,064 | $33.02 | – |
| 13 May 2026 | R. Graf | Independent Director | Other Derivative Acquisition | +21,872 | $30.76 | 21,872 |
| 13 May 2026 | Gary Sender | Independent Director | Other Derivative Acquisition | +21,872 | $30.76 | 21,872 |
| 13 May 2026 | Linda Szyper | Independent Director | Other Derivative Acquisition | +21,872 | $30.76 | 21,872 |
| 13 May 2026 | Geno Germano | Independent Director | Other Derivative Acquisition | +21,231 | $30.76 | 21,231 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 6,664,944 | 11.4% | 5.6 |
| 15 Oct 2026 | 5,413,347 | 9.3% | 6.2 |
| 30 Sep 2026 | 5,532,301 | 9.5% | 5.0 |
| 15 Sep 2026 | 4,628,716 | 7.9% | 4.3 |
| 31 Aug 2026 | 5,164,996 | 8.9% | 9.1 |
| 14 Aug 2026 | 4,136,259 | 7.1% | 4.8 |
No comments yet — be the first to weigh in on HRMY.
Sign in to join the discussion.